Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease
- 1 February 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 7 (2), 358-365
- https://doi.org/10.2215/cjn.04040411
Abstract
Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergocalciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.Keywords
This publication has 73 references indexed in Scilit:
- Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adultsJournal of Allergy and Clinical Immunology, 2011
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized TrialAmerican Journal of Kidney Diseases, 2009
- Vitamin D compounds for people with chronic kidney disease requiring dialysisEmergencias, 2009
- Vitamin D compounds for people with chronic kidney disease not requiring dialysisEmergencias, 2009
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increaseProceedings of the National Academy of Sciences of the United States of America, 2008
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General PopulationArchives of Internal Medicine, 2008
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006